Suramin is a polysulfonated naphthylurea originally designed as a treatment for trypanosomiasis; but that has also been used to treat rodent models of fulminant hepatic failure and focal brain ischemia. In this study, we determined the effects of suramin on renal ischemia/reperfusion-induced acute kidney injury in mice, in particular its effect when administered after renal injury has been established. Increasing concentrations of suramin were given 24 hours following reperfusion, a time when serum creatinine levels were at their highest level. This treatment improved renal function, as evidenced by decreased blood urea nitrogen and serum creatinine to control values and diminished histopathologic tubular damage. Suramin-treated animals had a significant reduction in apoptotic tubular cells and infiltrating leukocytes. There was also an increase of proliferating tubular cells following reperfusion compared to the number found in untreated animals. Our study shows that suramin promotes the recovery of renal function and has effective therapeutic applications when given after the occurrence of renal injury.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/ki.2008.506 | DOI Listing |
Int J Biol Sci
January 2025
Faculty of Health Sciences, University of Macau, Taipa, Macau.
Ion channels play a crucial role in cardiac functions, and their activities exhibit dynamic changes during heart development. However, the precise function of ion channels in human heart development remains elusive. In this study, we utilized human embryonic stem cells (hESCs) as a model to mimic the process of human embryonic heart development.
View Article and Find Full Text PDFCirc Res
March 2024
National Key Laboratory for Innovation and Transformation of Luobing Theory; The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences; Department of Cardiology, Qilu Hospital of Shandong University, Jinan, China (C.M., Y.L., Q.D., X.Q., H.L., M.Z., P.B., J.Y., Y.Z., C.Z., W.Z.).
Background: Many cardiovascular pathologies are induced by signaling through G-protein-coupled receptors via Gsα (G protein stimulatory α subunit) proteins. However, the specific cellular mechanisms that are driven by Gsα and contribute to the development of atherosclerosis remain unclear.
Methods: High-throughput screening involving data from single-cell and bulk sequencing were used to explore the expression of Gsα in atherosclerosis.
Cell Biol Int
March 2024
Division of Physiology, Kyushu Dental University, Fukuoka, Japan.
Dental pulp cells play a crucial role in maintaining the balance of the pulp tissue. They actively respond to bacterial inflammation by producing proinflammatory cytokines, particularly interleukin-6 (IL-6). While many cell types release adenosine triphosphate (ATP) in response to various stimuli, the mechanisms and significance of ATP release in dental pulp cells under inflammatory conditions are not well understood.
View Article and Find Full Text PDFLipids Health Dis
December 2023
Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, 100191, Beijing, China.
Background: Previous studies demonstrated that mast cells with their degranulated component heparin are the major endogenous factors that stimulate preadipocyte differentiation and promote fascial adipogenesis, and this effect is related to the structure of heparin. Regarding the structural and physiological properties of the negatively charged polymers, hexasulfonated suramin, a centuries-old medicine that is still used for treating African trypanosomiasis and onchocerciasis, is assumed to be a heparin-related analog or heparinoid. This investigation aims to elucidate the influence of suramin on the adipogenesis.
View Article and Find Full Text PDFParasitol Res
December 2023
Bob Champion Research and Education Building, Norwich Medical School, University of East Anglia, Norwich Research Park, Rosalind Franklin Road, Norwich, NR4 7UQ, UK.
Suramin was the first drug developed using the approach of medicinal chemistry by the German Bayer company in the 1910s for the treatment of human African sleeping sickness caused by the two subspecies Trypanosoma brucei gambiense and Trypanosoma brucei rhodesienese. However, the drug was politically instrumentalized by the German government in the 1920s in an attempt to regain possession of its former African colonies lost after the First World War. For this reason, the formula of suramin was kept secret for more than 10 years.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!